Category Archives: Science

Science Press Releases & News distributed via EuropaWire

Biotech Acceleration: Evotec and Claris Ventures Unite to Propel Portfolio Companies Forward

(IN BRIEF) Evotec and Claris Ventures have formed a strategic partnership to accelerate the progress of biotech ventures in Claris’s portfolio into clinical trials. This collaboration allows Claris’s portfolio companies, focused on biotech ventures nearing clinical trials, streamlined access to … Read the full press release

Novo Nordisk’s Semaglutide Shows Promise in Kidney Outcomes Trial FLOW

(IN BRIEF) Novo Nordisk has announced promising headline results from the kidney outcomes trial FLOW, which compared injectable semaglutide 1.0 mg with placebo as an adjunct to standard care for people with type 2 diabetes and chronic kidney disease (CKD). … Read the full press release

What’s new in cancer care across Europe in early 2024 (1 Jan – 5 Mar 2024): Advancements, Innovations, Research, Awareness

(IN BRIEF) In early 2024, Europe’s medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer, and AstraZeneca’s Tagrisso for EGFR-mutated lung cancer. Diagnostic advancements … Read the full press release

Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment

(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release

SGS Launches Comprehensive Solution for MoCRA Compliance

(IN BRIEF) SGS has introduced a comprehensive solution to support organizations in complying with the Modernization of Cosmetics Regulation Act (MoCRA) in the United States. MoCRA, which expands the FDA’s authority over cosmetic products, imposes new requirements on manufacturers and … Read the full press release

EMA Validates Marketing Authorisation Applications for AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan in Lung and Breast Cancer Treatment

(IN BRIEF) The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for datopotamab deruxtecan (Dato-DXd), developed by AstraZeneca and Daiichi Sankyo, for the treatment of nonsquamous non-small cell lung cancer (NSCLC) and hormone receptor (HR)-positive, HER2-negative breast … Read the full press release

Empathetic Communication Found Effective in Addressing Vaccine Hesitancy, Study Shows

(IN BRIEF) A groundbreaking international study led by the University of Bristol reveals the effectiveness of empathetic correction of misinformation in improving attitudes towards vaccination, particularly among vaccine-hesitant individuals. The research, published in Health Psychology, highlights the significance of empathetic … Read the full press release

Genetic Study Reveals Potential for Tailored Breast Cancer Screening

(IN BRIEF) A recent genetic study conducted by researchers at the University of Helsinki suggests that genetic risk information could revolutionize breast cancer screening, potentially benefiting one in ten women. The study indicates that a comprehensive genetic risk profile could … Read the full press release

Novartis Unveils Promising Results from SMART Study: Zolgensma’s Efficacy Confirmed in Older and Heavier SMA Patients

(IN BRIEF) Novartis has presented compelling data from the SMART study, reinforcing the clinical advantages of Zolgensma® (onasemnogene abeparvovec) in treating spinal muscular atrophy (SMA) patients weighing ≥ 8.5 kg to ≤ 21 kg, with a mean age of 4.69 … Read the full press release

Global Warming Amplifies Risks: UEA-Led Study Warns of Heightened Climate Threats to Developing Countries

(IN BRIEF) A research program led by the University of East Anglia (UEA) has quantified how climate change risks increase at a national scale with rising global temperatures. Focusing on six countries including Brazil, China, Egypt, Ethiopia, Ghana, and India, … Read the full press release

Sustainable Support: Repsol Powers Spanish Antarctic Campaign with 100% Renewable Energy

(IN BRIEF) Repsol, a leading energy company, is supplying 100% renewable fuels to power the Gabriel de Castilla Base during the Spanish Army’s 37th Antarctic Campaign. This initiative supports sustainability efforts in one of the most environmentally sensitive regions on … Read the full press release

Driving Environmental Excellence: Metso Elevates Emission Reduction Efforts with Cutting-Edge Scrubber Pilot Plant

(IN BRIEF) Metso has installed a state-of-the-art multi-purpose scrubber pilot plant at its R&D center in Frankfurt, Germany. This facility will focus on developing and optimizing gas cleaning processes, particularly simultaneous scrubbing of SO2 and NOx at low temperatures. Equipped … Read the full press release

Voydeya Recommended for EU Marketing Authorization as PNH Treatment Add-On

(IN BRIEF) Voydeya (danicopan), a first-in-class oral Factor D inhibitor, has been recommended for marketing authorization in the European Union (EU) as an add-on to ravulizumab or eculizumab for adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who experience residual haemolytic … Read the full press release

GSK’s Gepotidacin Shows Promise as Gonorrhoea Treatment: Positive Results from EAGLE-1 Trial

(IN BRIEF) GSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, an oral antibiotic aimed at treating uncomplicated urogenital gonorrhoea in adolescents and adults. The trial demonstrated gepotidacin’s non-inferiority compared to the current … Read the full press release

Boehringer Ingelheim’s Survodutide Shows Promising Results as Potential Best-in-Class Treatment for MASH in Phase II Trial

(IN BRIEF) Boehringer Ingelheim has reported compelling results from its Phase II trial of Survodutide, a novel glucagon/GLP-1 receptor dual agonist, indicating its potential to become a leading treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH). In the trial, up to 83.0% … Read the full press release

ZEISS and University of Oxford Collaborate to Advance Biomedical Imaging

(IN BRIEF) The University of Oxford and ZEISS have inaugurated the Oxford-ZEISS Centre of Excellence in Biomedical Imaging, promising cutting-edge microscopy and imaging technologies to further research in global health and disease. This collaboration between the Kennedy Institute of Rheumatology, … Read the full press release

Comprehensive Review in The Lancet Explores Atrial Fibrillation Risk Factors and Management

(IN BRIEF) A recent comprehensive review published in The Lancet Regional Health Europe offers insights into the risk factors and management strategies for atrial fibrillation (AF), a prevalent heart rhythm disorder affecting millions globally. Conducted by researchers from the University … Read the full press release

Graphene Flagship Culminates with Groundbreaking Findings and Innovations

(IN BRIEF) The Graphene Flagship, Europe’s largest-ever research initiative with a one billion Euro budget, concludes its ten-year journey, yielding significant insights into the health and environmental impacts of graphene and related materials. Empa researchers, including Peter Wick, have played … Read the full press release

The latest on quantum computing in Europe, January 2023 – February 2024

(IN BRIEF) Europe has made significant progress in quantum computing with investments, partnerships, and innovations. Highlights include a €3.5 million investment in LioniX International by the University of Twente, and T-Systems offering cloud access to IBM’s quantum systems. Other developments … Read the full press release

Heidelberg Materials and BirdLife International Renew Partnership for Biodiversity Conservation

(IN BRIEF) Heidelberg Materials and BirdLife International have extended their partnership to enhance biodiversity in and around the company’s quarries, minimize negative environmental impacts, and promote best practices in biodiversity management. The memorandum of understanding signed covers the next three … Read the full press release

Novo Nordisk Announces Annual General Meeting Date and Proposals for Board Re-election

(IN BRIEF) Novo Nordisk A/S has announced the date for its Annual General Meeting, scheduled for Thursday, March 21, 2024, at 14:00 CET. The meeting will be held partially electronically, allowing shareholders to participate either in person at Bella Center … Read the full press release

Fujitsu and QuTech Unveil Breakthrough in Quantum Computing: Ultra-Cold Electronics Revolutionize Diamond-Based Qubit Control

(IN BRIEF) Researchers from Fujitsu and QuTech have achieved a major breakthrough in quantum computing by developing ultra-cold electronic circuits to control diamond-based quantum bits (qubits). This advancement overcomes the ‘wiring bottleneck’ by enabling the operation of both qubits and … Read the full press release

Bristol Veterinary School Marks 75 Years of Leading Veterinary Medicine and Conservation

(IN BRIEF) In 2024, the University of Bristol’s Veterinary School commemorates 75 years of excellence in educating veterinary professionals and spearheading advancements in veterinary science. Established in 1949 following recommendations from the Loveday Committee, the school has evolved into a … Read the full press release

Ericsson and TDC NET Pioneer Virtual Reality Training for Engineers

(IN BRIEF) Ericsson and TDC NET have initiated a groundbreaking collaboration to provide Virtual Reality (VR) training for TDC NET’s engineers, marking the first of its kind in the Nordics. This innovative approach replaces traditional 2D screen training with immersive … Read the full press release

Evonik to Introduce New Class of rPEG Lipids for Enhanced Immunogenicity in Drug Delivery

(IN BRIEF) Evonik has partnered with the University of Mainz to commercialize a new class of polyethylene glycols (PEGs) called randomized polyethylene glycols (rPEGs). These rPEGs will be integrated into Evonik’s specialized lipid platform for drug delivery in nucleic acid-based … Read the full press release

Exploring Mars from Earth: Thales Alenia Space’s MARSBalloon Initiative Takes Flight

(IN BRIEF) Thales Alenia Space launches MARSBalloon 2024, a hands-on science project for primary and secondary students, aiming to spark interest in space exploration and science careers. Students design experiments to test various materials and conditions in a simulated Mars … Read the full press release

Higher Education Leaders Call for Ministerial Taskforce to Address Decline in Healthcare Course Applications

(IN BRIEF) In response to the latest UCAS data indicating a decline in applications for medicine, nursing, and midwifery courses, leaders from various higher education groups are urging the government to establish a ministerial taskforce. This taskforce would facilitate collaboration … Read the full press release

AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan Moves Closer to Approval for Advanced NSCLC Treatment

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted by the FDA for the treatment of locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) in patients who have undergone prior … Read the full press release

AstraZeneca’s Tagrisso Shows Promise in Phase III LAURA Trial for EGFR-Mutated Lung Cancer

(IN BRIEF) AstraZeneca’s Tagrisso (osimertinib) demonstrates significant improvement in progression-free survival (PFS) for patients with unresectable, Stage III EGFR-mutated non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT) in the LAURA Phase III trial. The trial, led by Dr. Suresh Ramalingam, … Read the full press release

FDA Approves AstraZeneca’s Tagrisso Plus Chemotherapy for EGFR-Mutated Lung Cancer

(IN BRIEF) AstraZeneca’s Tagrisso receives FDA approval for treating adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) following a Priority Review. The decision is based on FLAURA2 Phase III trial results demonstrating that Tagrisso plus … Read the full press release

Almirall Achieves Robust Growth in Dermatology Sector, Expands Pipeline with Licensing Agreement

(IN BRIEF) Almirall, a leading biopharmaceutical company specializing in medical dermatology, has reported its full-year 2023 financial results, showcasing a 4% year-on-year growth in net sales driven by the strong performance of its European Dermatology business. The company’s total EBITDA … Read the full press release

Almirall Secures Global Rights for Promising Dermatological Treatment, NN-8828, Targeting IL-21

(IN BRIEF) Almirall S.A., a leading pharmaceutical company specializing in medical dermatology, has finalized an exclusive license agreement with Novo Nordisk for the development and commercialization of NN-8828, an IL-21 blocking monoclonal antibody. This innovative treatment holds potential for various … Read the full press release

Dupixent® Receives Landmark Approval in Japan for Chronic Spontaneous Urticaria Treatment

(IN BRIEF) Japan’s Ministry of Health, Labor and Welfare (MHLW) has authorized the marketing and manufacturing of Dupixent® (dupilumab) for treating chronic spontaneous urticaria (CSU) in patients aged 12 years and older. This approval marks a significant milestone as Japan … Read the full press release

Harnessing Online Data to Combat Biodiversity Crisis: University of Helsinki Study

(IN BRIEF) A study led by Dr. Andrea Soriano-Redondo and researchers from the University of Helsinki proposes leveraging online digital data, including social media posts, news articles, and image-sharing platforms, to complement traditional biodiversity monitoring efforts. Published in the journal … Read the full press release

University of Helsinki Study Reveals Temperature-Dependent Splitting of Quadruply Quantized Vortices in Superfluids

(IN BRIEF) A recent study from the University of Helsinki sheds light on the behavior of quadruply quantized vortices in superfluids, demonstrating that these vortices can split in three distinct ways depending on temperature. Led by doctoral researcher Xin Li, … Read the full press release

Newcastle University Lecturer Honored with National Award for Surgical Innovation

(IN BRIEF) Dr. Kenneth Rankin, an honorary senior lecturer at Newcastle University, was bestowed with the prestigious Researcher of the Year award at The Bone Idols 2024 ceremony for his outstanding contributions to surgical oncology. Recognized for his remarkable innovation … Read the full press release

UEA Launches £1.1 Million Project to Enhance Mental Health Support for Teens in Care

(IN BRIEF) The University of East Anglia (UEA) embarks on “LIMITLESS II,” a £1.1 million endeavor funded by the National Institute for Health and Care Research (NIHR), aimed at enhancing mental health support for teenagers living in care. Led by … Read the full press release

EIB Injects €143 Million to Bolster Greek Research & Innovation; 2023 Annual Results Showcase Record Investment in Greece

(IN BRIEF) The European Investment Bank (EIB) has pledged a substantial €143 million loan to boost the Hellenic Foundation for Research and Innovation (HFRI), fortifying research and development (R&D) initiatives across Greece’s public higher education institutions and research centers. This … Read the full press release

Unveiling Prehistoric Life: Star Carr Exhibition at Yorkshire Museum Showcases Mesolithic Artefacts

(IN BRIEF) A remarkable exhibition at the Yorkshire Museum, titled “Star Carr: Life after the ice,” unveils a treasure trove of artefacts discovered during excavations led by a University of York researcher at the renowned Middle Stone Age site of … Read the full press release

Empa Researcher Awarded Entrepreneur Fellowship to Harness Industrial Waste Heat with Innovative Technology

(IN BRIEF) Empa researcher Andyn Omanovic, in collaboration with etavalve GmbH, a spin-off of Empa and ETH Zurich, is poised to revolutionize the utilization of industrial waste heat. Omanovic’s innovative piston machine, equipped with an electro-hydraulically actuated valve control system, … Read the full press release